NEW YORK, April 9 – Spotfire said Monday that it has signed agreements with both Celera and Biogen for use of Spotfire’s DecisionSite analytical software.

Celera and Spotfire will integrate DecisionSite, which enables visual analysis of product, process, and customer information from a variety of sources, with the Celera Discovery System, which provides access to Celera’s human, mouse, and fly genomes as well as other biological databases. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.